Electroid D

Manufacturer: Intervet/Schering-Plough Animal Health

Clostridium perfringens Type D Toxoid

U.s. Vet. Lic. No.

311

Contents

Clostridium perfringens Type D toxoid.

Electroid D Indications

For the vaccination of healthy cattle and sheep against disease caused by Clostridium perfringens Type D.

Electroid D Dosage And Administration

Shake well. Using aseptic technique, inject subcutaneously or intramuscularly. Cattle, 4 mL; sheep, 2 mL, repeated in 3 to 4 weeks. Revaccinate annually prior to periods of extreme risk or parturition.

Precaution(s)

Store at 35°-45°F (2°-7°C). Protect from freezing. Use entire contents when first opened.

Electroid D Caution(s)

Anaphylactoid reactions may occur following use.

This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy. This level of performance may be affected by conditions of use such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.

Local reactions may be observed following subcutaneous administration to cattle.

Antidote(s)

Epinephrine.

Warning(s)

Do not vaccinate within 21 days before slaughter.

For veterinary use only.

Presentation

500 mL vials (125 cattle doses/250 sheep doses).

Manufactured By

Schering-Plough Animal Health Limited

Nac No.

10470570